- Geisinger Health was recently named by the Centers for Medicare & Medicaid Services among the 25 candidates advancing to the first stage of its AI Health Outcomes challenge.- The CMS AI Health Outcomes challenge provides innovators with the opportunity to demonstrate how AI tools may be implemented to predict health outcomes and keep patients healthy in hopes of more AI tools being considered for potential use in CMS Innovation Center payment and service delivery models. Geisinger, an
Read More
CMS Launches $1.65M Artificial Intelligence Health Outcomes Challenge
This week, the Centers for Medicare & Medicaid Services (CMS) announced the launch of their first-ever Artificial Intelligence Health Outcomes Challenge. The three-stage competition accelerates artificial intelligence (AI) solutions to better predict health outcomes such as unplanned hospital and skilled nursing facility admissions and adverse events for potential use by the Innovation Center in testing innovative payment and service delivery models under the authority of section 1115A of
Read More
CMS Unveils “New Direction” for Innovation Center to Promote Patient-Centered Care
The Centers for Medicare & Medicaid Services (CMS) has unveiled a “new direction for the Innovation Center” to promote patient-centered care and test market-driven reforms. The goal of this new direction for the CMS Innovation Center will empower beneficiaries as consumers, provide price transparency, increase choices and competition to drive quality, reduce costs, and improve outcomes.The CMS Innovation Center will carefully evaluate how models developed consistent with the new directions
Read More
NantCare Unveils Solutions to Support CMS Oncology Care Model
NantCare, a member of the NantWorks will be providing community oncology practices with solutions and resources that will help these practices comply with the administrative and clinical requirements put forth by the CMS’ new Oncology Care Model (OCM). Typically only available at large cancer institutions, NantCare will provide access to clinical trials through facilitation of participation in Cancer MoonShot 2020’s QUILT Trials, eliminating the need for patients to travel to major cancer
Read More
